These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2993889)

  • 1. Hepatic encephalopathy.
    Fraser CL; Arieff AI
    N Engl J Med; 1985 Oct; 313(14):865-73. PubMed ID: 2993889
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-ketoglutaramate, a neurotoxic agent in hepatic coma.
    Vergara F; Duffy TE; Plum F
    Trans Assoc Am Physicians; 1973; 86():255-63. PubMed ID: 4788800
    [No Abstract]   [Full Text] [Related]  

  • 3. Recognition and management of acute and chronic hepatic encephalopathy.
    Jacobson S; Bell B
    Med Clin North Am; 1973 Nov; 57(6):1569-77. PubMed ID: 4583596
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of lactulose and neomycin in the treatment of porto-systemic encephalopathy].
    Sala Felis T; Berenguer J; Barrios JM; Gómez J
    Rev Esp Enferm Apar Dig; 1974 Feb; 42(3):335-42. PubMed ID: 4829021
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of hepatic encephalopathy. Personal experience and a review of the literature].
    Cipollini F; Amadio R; Altilia F
    G Clin Med; 1982 Oct; 63(10):753-67. PubMed ID: 6133806
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?].
    MMW Fortschr Med; 2000 Jun; 142(25):56-7. PubMed ID: 10920673
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic encephalopathy: pathophysiology and emerging therapies.
    Sundaram V; Shaikh OS
    Med Clin North Am; 2009 Jul; 93(4):819-36, vii. PubMed ID: 19577116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypernatremia and lactulose therapy.
    Nelson DC; McGrew WR; Hoyumpa AM
    JAMA; 1983 Mar; 249(10):1295-8. PubMed ID: 6827705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-ketoglutaramate in hepatic encephalopathy.
    Duffy TE; Vergara F; Plum F
    Res Publ Assoc Res Nerv Ment Dis; 1974; 53():39-52. PubMed ID: 4438817
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl)].
    Leonhardt H; Sanhueza P
    Med Klin; 1978 Jan; 73(2):63-8. PubMed ID: 622058
    [No Abstract]   [Full Text] [Related]  

  • 11. [Emergency treatment of hepatic coma and porto-caval encephalopathy].
    Imler M
    Bull Soc Sci Med Grand Duche Luxemb; 1973 Nov; 110(2):239-55. PubMed ID: 4589247
    [No Abstract]   [Full Text] [Related]  

  • 12. Lactulose-induced hypernatremia.
    Nanji AA; Lauener RW
    Drug Intell Clin Pharm; 1984 Jan; 18(1):70-1. PubMed ID: 6692744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal-systemic encephalopathy and hepatic coma.
    Jensen DM
    Med Clin North Am; 1986 Sep; 70(5):1081-92. PubMed ID: 2874273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactulose in the treatment of acute hepatic encephalopathy.
    Fessel JM; Conn HO
    Am J Med Sci; 1973 Aug; 266(2):103-10. PubMed ID: 4742364
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
    Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
    Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ammonia abolishers: antibiotics for hepatic encephalopathy.
    Felicilda-Reynaldo RF
    Medsurg Nurs; 2012; 21(3):173-5; quiz 176. PubMed ID: 22866441
    [No Abstract]   [Full Text] [Related]  

  • 17. Portal systemic encephalopathy--should lactulose and neomycin be used together.
    Martin AJ
    Br J Clin Pract; 1981 Sep; 35(9):323-4. PubMed ID: 7326185
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatic encephalopathy.
    Davidoff S; Werbitt W
    J Med Soc N J; 1982 Nov; 79(12):919-22. PubMed ID: 6960190
    [No Abstract]   [Full Text] [Related]  

  • 19. [The level of ammonia and its metabolites in the brain in experimental hepatic encephalopathy induced by long-term administration of thioacetamine and during recovery].
    Hilgier W; Albrecht J
    Neuropatol Pol; 1984; 22(2):179-84. PubMed ID: 6483197
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic encephalopathy: current status.
    Schenker S; Breen KJ; Hoyumpa AM
    Gastroenterology; 1974 Jan; 66(1):121-51. PubMed ID: 4588556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.